Physician profile

Neel R Kumar

Emergency Medicine · Bronx, NY

NPI 1205958139

$554.85

in general payments reported to CMS, 2019-2025

5 companies · $161 in 2025

The $161 reported for 2025 was more than what 77% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$277.52

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Immunitybio, INC. $161.45 2025
Janssen Biotech, INC. $121.58 2022
Merck Sharp & Dohme LLC $116.07 2024 Keytruda
Astrazeneca Pharmaceuticals LP $103.00 2021
Urogen Pharma, INC. $52.75 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Neel R Kumar

$554.85

in general payments reported 2019-2025

Years
2021-2025
Top company
Immunitybio, INC.
Context
The $161 reported for 2025 was more than what 77% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).

https://glasscript.com/doctor/454754/neel-r-kumar

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.